[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
March 25, 1998

Incorrect Wording

JAMA. 1998;279(12):913. doi:10.1001/jama.279.12.913

In the From the Food and Drug Administration column published in the February 4, 1998, issue of THE JOURNAL (1998;279:346), there was incorrect wording under the heading "Two New Warnings Added to Labeling for Mibefradil." Mibrefadil is not contraindicated for patients concurrently receiving fluvastatin. The 2 drugs for which a new warning states that concurrent use with Mibefradil is contraindicated are lovastatin and simvastatin.

×